Genome Editing Market Revenue to Cross USD 10 Bn by 2026: Global Market Insights, Inc.

Oct 5, 2020

Asia Pacific genome editing market will showcase growth of 15% during the forecast period owing to increasing number of genetic research organizations in emerging economies that are working on the development of innovative gene-editing tools.



SELBYVILLE, Del. - October 5, 2020 - (Newswire.com)

​According to the latest report "Genome Editing Market by Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), Technology (CRISPR/Cas9, Zinc Finger Nucleases, TALENs), End-user (Biotech and Pharma Companies, Contract Research Organizations, Research Institutes), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026", by Global Market Insights, Inc., the market valuation of genome editing will cross $10 billion by 2026. Increasing government support for the better treatment of genetic diseases will enhance the market growth.

Growing R&D expenditure by pharmaceutical and biopharmaceutical companies as well as research institutes will positively impact the market revenue. Several biopharmaceutical firms have raised their R&D operations and expenditures that enables the availability of technologically advanced gene-editing techniques at a lower cost. Furthermore, the considerable growth of the biotechnology sector in developed countries will provide numerous opportunities for market expansion.

Request a sample of this research report @

https://www.gminsights.com/request-sample/detail/810

The TALENs technology segment size was around USD 650 million in 2019. TALENs offers high target site specificity that enables researchers in making precise genetic modifications, surging its adoption rate. TALENs pair can be targeted to any genome site, providing more flexibility and freedom in target site selection. Also, TALENs genome editing tool is used to correct the genomic errors that can cause various disorders including xeroderma pigmentosum, sickle cell disorder and epidermolysis bullosa. The plant genetic engineering application held over 19% of the market share in 2019 due to the availability of technologically advanced genome editing procedures utilized in modifying plant genome coupled with a surging preference for genetically modified crops. Genetically modified crops have several benefits in terms of raising agricultural productivity as well as reducing the need for environmentally harmful pesticides.

The contract research organizations (CROs) segment in the genome editing market accounted for USD 900 million in 2019. Several CROs are trying to develop advanced gene-editing tools such as TALENS and CRISPR/Cas9. PSI, Med pace and ACF Bio services are some of the major CROs working on developing advanced genome editing tools. Additionally, CROs have experts with in-depth knowledge of the developments and regulations related to advanced genome therapy products, fostering the segment growth.

Asia Pacific genome editing market will showcase the growth of 15% during the forecast period owing to the increasing number of genetic research organizations in emerging economies that are working on the development of innovative gene-editing tools. Surging research activities for genome editing in developing countries such as India, Japan and others will prove beneficial for the regional market progression.

Some of the prominent players operating in the genome editing market are Integrated DNA Technologies, Horizon Discovery, Agilent Technologies, Takara Bio, Sangamo Therapeutics, Thermo Fisher Scientific, Precision Biosciences, Inc., EMD Millipore (Merck KGAa), Origene Technologies, Caribou Biosciences, and Beam Therapeutics.

These companies are implementing various growth strategies such as collaborations and partnerships, mergers, novel product launch, in order to increase their market share. For instance, in May 2019, Integrated DNA Technologies launched ultra-high performance CRISPR Cas12a enzyme known as Alt-R Cas12a (Cpf1) ultra. The system makes it easier to attain precision genome editing at novel sites across genomes. This launch helped the company to expand their business portfolio.

Request customization of this research report @

https://www.gminsights.com/roc/810

Table of Contents (ToC) of the report:

Chapter 3. Genome Editing Market Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.2. Industry pitfalls and challenges

3.4. Growth potential analysis

3.4.1. By application

3.4.2. By technology

3.4.3. By end-user

3.5. COVID-19 impact analysis

3.6. Competitive landscape, 2019

3.6.1. Strategy dashboard, 2019

3.7. Porter's analysis

3.8. PESTEL analysis

Browse Complete Table of Contents (ToC) @

https://www.gminsights.com/toc/detail/gene-editing-market

About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected]


Related Links
Cancer Gene Therapy Market Trends
Precision Medicine Market Trends



Press Release Service by Newswire.com

Original Source: Genome Editing Market Revenue to Cross USD 10 Bn by 2026: Global Market Insights, Inc.

More News

GISBH: KPWKM prioritises swift reunification of rescued children with families

GISBH: KPWKM prioritises swift reunification of rescued children with families

Oct 15, 2024

KUALA LUMPUR: The immediate return of children rescued during Op Global to their parents and families is a top priority for the Ministry of Women, Family and Community Development (KPWKM). However, its minister, Datuk Seri Nancy Shukri said KPWKM must first ensure that the children’s parents and families can provide adequate and proper care. “For cases where the capability of the parents and families is clearly established, the reunification process can proceed without delay. In more complex situations, intervention programmes will be implemented to ensure the children’s and families’ best interests are safeguarded “The ultimate goal is to reunite these children with their families. However, before this can happen, several factors need to be carefully evaluated. This is not about denying anyone’s rights, but about ensuring the best interests of the children are upheld,” Nancy said during a minister’s briefing session on GISB Holdings Sdn Bhd (GISBH) in the Dewan Rakyat today. As of yesterday, 560 children – 283 boys and 277 girls – had been placed in safe custody after the Social Welfare Department (JKM) obtained a temporary court custody order for two months under Section 25(2)(a) of the Child Act 2001. Meanwhile, Nancy said the Task Force Profiling Team for Op Global found that 94.3 per cent of the 558 profiled children had at least one living biological parent, while 5.7 per cent had no parents or no available information on their parents. Health assessments showed that 51.6 per cent of the children were underweight, falling below the healthy Body Mass Index (BMI), while 46.1 per cent had a normal weight and the remaining children were classified as obese, she added. “Three children have been issued persons with disabilities (PwD) cards, while 27 others display symptoms of disability,” she added. Cognitive assessments were also conducted on 385 children aged seven and above, with 71.9 per cent (277 children) showing no signs of cognitive disorders, she said. “However, 20.26 per cent (78 children) displayed moderate cognitive disorders, while 7.79 per cent (30 children) were found to have severe cognitive impairments,” Nancy said.

Investigations ongoing into incident of empty Johor checkpoint counters with green lights on, blocked pathways

Investigations ongoing into incident of empty Johor checkpoint counters with green lights on, blocked pathways

Oct 15, 2024

PETALING JAYA: A surprise inspection by Johor Public Works, Transport, Infrastructure, and Communications committee chairman, Mohamad Fazli Mohamad Salleh recently found 17 Immigration counters at the Johor checkpoint empty. The inspection was conducted following a video circulating online showing the 17 empty counters at the checkpoint in Sultan Abu Bakar Complex (KSAB), triggering public backlash. He confirmed that the surprise inspection found that the incident actually occurred, Harian Metro reported. The video showed the empty counters, with green lights on however, the pathways were closed off to commuters. ALSO READ: Woman calls out Immigration officer for alleged rude behaviour Fazli then instructed that the green lights to be turned off to indicate that the lane is closed, to ensure no one is confused. “If there is no solid reason given regarding the incident, this can be considered intentional,” he was quoted as saying. On the other hand, Johor Immigration director Datuk Mohd Rusdi Mohd Darus said an internal probe will be conducted on the incident. ALSO READ: Woman expresses gratitude to Johor Immigration officers for returning lost RM1.5k “The internal investigation will determine whether the immigration officer handling the counter neglected their duties or intentionally left the counter without permission. “We will not tolerate this behaviour, and strict disciplinary action will be taken against them if they are found to have neglected their duties. “It is a violation of responsibility, and I take this issue seriously,“ he was quoted as saying.

Malaysia should seize opportunity in global medical devices market - Chang

Malaysia should seize opportunity in global medical devices market - Chang

Oct 15, 2024

KUALA LUMPUR: Malaysian innovators and manufacturers should seize the opportunity to tap into the immense potential of the global medical devices industry, which is projected to reach nearly US$800 billion by 2030, says Science, Technology and Innovation (MOSTI) Minister Chang Lih Kang. Chang noted that Malaysia had many high-quality products and innovators in the medical devices sector, with the government continuously encouraging and supporting industry players in research and development (R&D) and commercialisation efforts. “The market is vast, and we have plenty of room for success. To support R&D, of course, not limited to the medical devices industry, MOSTI offers various funding facilities, grants, matching grants, and equity where we invest in relevant startups,” he said. Chang said this to reporters after officiating the soft launch of INNOMed: Innovation Pitching Powered by PERANTIM, a key event in the International Medical Device Exhibition & Conference (IMDEC) 2024. Also present were Medical Device Authority (MDA) chief executive officer Dr P. Muralitharan, Malaysia Medical Devices Manufacturers Association (PERANTIM) president Johari Abu Kasim, and organising chairman of INNOMed, Dr Hyzan Mohd Yusof. Earlier in his speech, Chang said that under Malaysia’s New Industrial Master Plan (NIMP) 2030, the government aimed to foster synergies between the manufacturing and engineering sectors and the medical devices sector. This includes creating advanced inspection tools, solutions for imaging and endoscopy, implantable devices, and minimally invasive surgical tools. Meanwhile, Muralitharan told Bernama that, according to figures from the Department of Statistics Malaysia (DOSM), Malaysia’s total trade in medical devices, valued at RM25.61 billion from January to July this year, increased by 23.5 per cent compared to the same period in 2023 (RM20.74 billion). He added that the export of medical devices was valued at RM20.15 billion, an increase of 25.7 per cent compared to RM16.02 billion in 2023. In his speech, Dr Hyzan said that medical device innovation presented an opportunity to improve healthcare while boosting the economy, with the industry projected to reach nearly US$2 billion by 2025, making it one of the fastest-growing sectors. “By focusing on innovation, we can create high-skilled jobs, reduce our dependence on imported technologies, and position Malaysia as a global leader. Last year, we spent US$5 billion on medical devices, with 95 per cent being imports. Our goal is to reduce this to 50 per cent within five years,” he said. He also emphasised that close collaboration among universities, innovators, manufacturers, clinicians, and government agencies was key to ensuring that ideas and research transitioned smoothly from laboratories to clinical applications and into the hands of healthcare providers. INNOMed, themed “Unleashing the Power of Medical Technology: Shaping the Future of Healthcare,“ is organised by the MDA and will take place from Dec 10 to 12 at the Kuala Lumpur Convention Centre (KLCC).

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Utara Selatan

Bringing you from Utara to Selatan, we publish travel guides to make sure you will discover new places to visit in Malaysia and try all the local delicacies.

Newsletter